EXHIBIT 99.2

        VCA Antech, Inc. Updates Financial Guidance for Fiscal Year 2007

     LOS ANGELES--(BUSINESS WIRE)--April 25, 2007--VCA Antech, Inc.
(NASDAQ:WOOF), a leading animal healthcare company in the United States,
provides the following revised financial guidance for all investors in adherence
with Regulation Fair Disclosure as issued by the United States Securities and
Exchange Commission, the SEC. We encourage all current and potential investors
to review the disclosure regarding forward-looking statements in this press
release as well as in all financial documents filed with the SEC.

     We are providing the following revised financial guidance for the year
ending December 31, 2007:

     -- Revenue of $1.08 billion to $1.09 billion; and

     -- Diluted earnings per common share of $1.31 to $1.35.

     Forward-Looking Statements

     This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995, including our financial
guidance for fiscal year 2007. Among the important factors that could cause
actual results to differ are: a material adverse change in our financial
condition or operations; the rate of our laboratory internal revenue growth and
animal hospital same-store revenue growth; the level of direct costs and our
ability to maintain revenue at a level necessary to maintain expected operating
margins; the level of selling, general and administrative costs; the effects of
our recent acquisitions and our ability to effectively manage our growth and
achieve operating synergies; a continued decline in demand for some of our
products and services; any disruption in our information technology systems or
transportation networks; the effects of competition; any impairment in the
carrying value of our goodwill; changes in prevailing interest rates; our
ability to service our debt; and general economic conditions. These and other
risk factors are discussed in our Report on Form 10-K for the year ended
December 31, 2006, and the reader is directed to these statements for a further
discussion of important factors that could cause actual results to differ
materially from those in the forward-looking statements.

     We own, operate and manage the largest networks of freestanding veterinary
hospitals and veterinary-exclusive clinical laboratories in the country, and we
supply diagnostic imaging equipment to the veterinary industry.


     CONTACT: VCA Antech, Inc.
              Tomas Fuller, Chief Financial Officer, 310-571-6505